Xiwei Ding
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Cancer Cells and Metastasis
- Drug Transport and Resistance Mechanisms
- Pancreatic and Hepatic Oncology Research
Papers in
- Surgery 15
- Cholangiocarcinoma and Gallbladder Cancer Studies 12
-
- Gastric Cancer Management and Outcomes 7
- Gallbladder and Bile Duct Disorders 4
- Co-authors
- Junhua Wu (1 shared paper)Chunping Jiang (1 shared paper)Xiaoping Zou (18 shared papers)Shuling Huang (4 shared papers)Xiaoping Zou (6 shared papers)Ying Lv (13 shared papers)Qingguo Li (1 shared paper)Decai Yu (1 shared paper)
- Journals
- Surgical Endoscopy (4 papers)BMC Gastroenterology (3 papers)Frontiers in Oncology (2 papers)Cell Death and Disease (2 papers)International Immunopharmacology (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Xiwei Ding
42 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 78
- Cancer Research 202
- Oncology 319
- Pulmonary and Respiratory Medicine 300
- Molecular Biology 297
- Surgery 199
Countries citing papers authored by Xiwei Ding
This map shows the geographic impact of Xiwei Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiwei Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiwei Ding more than expected).
Fields of papers citing papers by Xiwei Ding
This network shows the impact of papers produced by Xiwei Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiwei Ding. The network helps show where Xiwei Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiwei Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 278 | |
| 2 | 2012 | 99 | |
| 3 | 2011 | 87 | |
| 4 | 2023 | 84 | |
| 5 | 2016 | 74 | |
| 6 | 2021 | 50 | |
| 7 | 2016 | 49 | |
| 8 | 2021 | 49 | |
| 9 | 2020 | 42 | |
| 10 | 2013 | 39 | |
| 11 | 2021 | 38 | |
| 12 | 2018 | 35 | |
| 13 | 2019 | 35 | |
| 14 | 2014 | 34 | |
| 15 | BRD4 degrader ARV-825 produces long-lasting loss of BRD4 protein and exhibits potent efficacy against cholangiocarcinoma cells. | 2019 | 32 |
| 16 | 2015 | 31 | |
| 17 | 2014 | 27 | |
| 18 | 2021 | 27 | |
| 19 | 2021 | 26 | |
| 20 | 2016 | 24 |
About Xiwei Ding
Xiwei Ding is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Gastroenterology, having authored 44 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers), Gastric Cancer Management and Outcomes (7 papers), Pancreatic and Hepatic Oncology Research (5 papers), Gallbladder and Bile Duct Disorders (4 papers), Cancer-related molecular mechanisms research (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), AI in cancer detection (2 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Cancer Research (202 citations), Oncology (319 citations), Pulmonary and Respiratory Medicine (300 citations), Molecular Biology (297 citations) and Surgery (199 citations). Xiwei Ding has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Junhua Wu, Chunping Jiang, Xiaoping Zou, Shuling Huang, Xiaoping Zou, Ying Lv, Qingguo Li, Decai Yu, Gang Chen and Min Chen. Their work appears in journals such as Surgical Endoscopy, BMC Gastroenterology, Frontiers in Oncology, Cell Death and Disease and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.